Scott Gleason | Myriad Genetics, Inc. |
Mark C. Capone | Myriad Genetics, Inc. |
R. Bryan Riggsbee | Myriad Genetics, Inc. |
Jack Meehan | Barclays Capital, Inc. |
Doug Schenkel | Cowen & Co. LLC |
Amanda L. Murphy | William Blair & Co. LLC |
Tycho W. Peterson | JPMorgan Securities LLC |
William R. Quirk | Piper Jaffray & Co. |
Hello, ladies and gentlemen, thank you for standing by, and welcome to Myriad Genetics First Quarter 2018 Financial Earnings Conference Call.
Now, during today's call, all participants will start in a listen-only mode, but later, we'll conduct a question-and-answer session. Please note, today's conference call is being recorded. And it is now my pleasure to introduce Scott Gleason. Please go ahead, sir.